{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:25:31Z","timestamp":1784082331951,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,30]]},"DOI":"10.7759\/cureus.74865","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T01:30:30Z","timestamp":1733016630000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Acute Pyelonephritis in Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Priyatharicini","family":"Anandasekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumal Valavan","family":"Kaliaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Ramasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin Fernando","family":"Mervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050. a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023, 402:203-34. 10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.111637","article-title":"Complicated urinary tract infections associated with diabetes mellitus: pathogenesis, diagnosis and management","volume":"17","author":"Mnif MF","year":"2013","unstructured":"Mnif MF, Kamoun M, Kacem FH, et al.. Complicated urinary tract infections associated with diabetes mellitus: pathogenesis, diagnosis and management. Indian J Endocrinol Metab. 2013, 17:442-5. 10.4103\/2230-8210.111637","journal-title":"Indian J Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i10.3268","article-title":"Emphysematous pyelonephritis: six case reports and review of literature","volume":"10","author":"Ma LP","year":"2022","unstructured":"Ma LP, Zhou N, Fu Y, Liu Y, Wang C, Zhao B. Emphysematous pyelonephritis: six case reports and review of literature. World J Clin Cases. 2022, 10:3268-77. 10.12998\/wjcc.v10.i10.3268","journal-title":"World J Clin Cases"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5152\/tud.2016.86155","article-title":"Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients","volume":"43","author":"Nigussie D","year":"2017","unstructured":"Nigussie D, Amsalu A. Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients. Turk J Urol. 2017, 43:85-92. 10.5152\/tud.2016.86155","journal-title":"Turk J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S51792","article-title":"Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management","volume":"8","author":"Nitzan O","year":"2015","unstructured":"Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015, 8:129-36. 10.2147\/DMSO.S51792","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2017_21","article-title":"Urinary tract infection and diabetes mellitus-etio-clinical profile and antibiogram: a North Indian perspective","volume":"11","author":"Jagadeesan S","year":"2022","unstructured":"Jagadeesan S, Tripathi BK, Patel P, Muthathal S. Urinary tract infection and diabetes mellitus-etio-clinical profile and antibiogram: a North Indian perspective. J Family Med Prim Care. 2022, 11:1902-6. 10.4103\/jfmpc.jfmpc_2017_21","journal-title":"J Family Med Prim Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S147078","article-title":"Prevalence, risk factors and microorganisms of urinary tract infections in patients with type 2 diabetes mellitus: a retrospective study in China","volume":"14","author":"He K","year":"2018","unstructured":"He K, Hu Y, Shi JC, Zhu YQ, Mao XM. Prevalence, risk factors and microorganisms of urinary tract infections in patients with type 2 diabetes mellitus: a retrospective study in China. Ther Clin Risk Manag. 2018, 14:403-8. 10.2147\/TCRM.S147078","journal-title":"Ther Clin Risk Manag"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5464","article-title":"Clinical and microbiological profile of urinary tract infections in diabetic versus non-diabetic individuals","volume":"11","author":"Kumar R","year":"2019","unstructured":"Kumar R, Kumar R, Perswani P, Taimur M, Shah A, Shaukat F. Clinical and microbiological profile of urinary tract infections in diabetic versus non-diabetic individuals. Cureus. 2019, 11:e5464. 10.7759\/cureus.5464","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4038\/jmj.v32i2.101","article-title":"Emphysematous pyelonephritis","volume":"32","author":"Balagobi B","year":"2020","unstructured":"Balagobi B, Nitharsanan M, Thanusan V. Emphysematous pyelonephritis. Jaffna Med J. 2020, 32:6-10. 10.4038\/jmj.v32i2.101","journal-title":"Jaffna Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.559595","article-title":"Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia","volume":"9","author":"Ch\u00e1vez-Reyes J","year":"2021","unstructured":"Ch\u00e1vez-Reyes J, Esc\u00e1rcega-Gonz\u00e1lez CE, Chavira-Su\u00e1rez E, et al.. Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Front Public Health. 2021, 9:559595. 10.3389\/fpubh.2021.559595","journal-title":"Front Public Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/life13020539","article-title":"The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update","volume":"13","author":"Wu T","year":"2023","unstructured":"Wu T, Ding L, Andoh V, Zhang J, Chen L. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life (Basel). 2023, 13:539. 10.3390\/life13020539","journal-title":"Life (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20190077","article-title":"Kidney disease in diabetes mellitus: cross-linking between hyperglycemia, redox imbalance and inflammation","volume":"112","author":"Amorim RG","year":"2019","unstructured":"Amorim RG, Guedes GD, Vasconcelos SM, Santos JC. Kidney disease in diabetes mellitus: cross-linking between hyperglycemia, redox imbalance and inflammation. Arq Bras Cardiol. 2019, 112:577-87. 10.5935\/abc.20190077","journal-title":"Arq Bras Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2020.102736","article-title":"Autonomic neuropathy and urologic complications in diabetes","volume":"229","author":"Agochukwu-Mmonu N","year":"2020","unstructured":"Agochukwu-Mmonu N, Pop-Busui R, Wessells H, Sarma AV. Autonomic neuropathy and urologic complications in diabetes. Auton Neurosci. 2020, 229:102736. 10.1016\/j.autneu.2020.102736","journal-title":"Auton Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110762","article-title":"Autonomic diabetic neuropathies: a brief overview","volume":"206","author":"Pop-Busui R","year":"2023","unstructured":"Pop-Busui R. Autonomic diabetic neuropathies: a brief overview. Diabetes Res Clin Pract. 2023, 206:110762. 10.1016\/j.diabres.2023.110762","journal-title":"Diabetes Res Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.135347","article-title":"Acute pyelonephritis in diabetes mellitus: single center experience","volume":"24","author":"Kumar S","year":"2014","unstructured":"Kumar S, Ramachandran R, Mete U, et al.. Acute pyelonephritis in diabetes mellitus: single center experience. Indian J Nephrol. 2014, 24:367-71. 10.4103\/0971-4065.135347","journal-title":"Indian J Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr810","article-title":"Acute pyelonephritis in adults: a case series of 223 patients","volume":"27","author":"Rollino C","year":"2012","unstructured":"Rollino C, Beltrame G, Ferro M, Quattrocchio G, Sandrone M, Quarello F. Acute pyelonephritis in adults: a case series of 223 patients. Nephrol Dial Transplant. 2012, 27:3488-93. 10.1093\/ndt\/gfr810","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.17034","article-title":"Effect of cefepime\/enmetazobactam vs piperacillin\/tazobactam on clinical cure and microbiological eradication in patients with complicated urinary tract infection or acute pyelonephritis: a randomized clinical trial","volume":"328","author":"Kaye KS","year":"2022","unstructured":"Kaye KS, Belley A, Barth P, Lahlou O, Knechtle P, Motta P, Velicitat P. Effect of cefepime\/enmetazobactam vs piperacillin\/tazobactam on clinical cure and microbiological eradication in patients with complicated urinary tract infection or acute pyelonephritis: a randomized clinical trial. JAMA. 2022, 328:1304-14. 10.1001\/jama.2022.17034","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.352425","article-title":"Emphysematous pyelonephritis in type 2 diabetes - clinical profile and management","volume":"32","author":"Bhat SK","year":"2021","unstructured":"Bhat SK, Srivastava A, Ansari NA, et al.. Emphysematous pyelonephritis in type 2 diabetes - clinical profile and management. Saudi J Kidney Dis Transpl. 2021, 32:1646-54. 10.4103\/1319-2442.352425","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00640-y","article-title":"Comparative study of emphysematous pyelonephritis and pyelonephritis in type 2 diabetes: a single-centre experience","volume":"19","author":"Nabi T","year":"2020","unstructured":"Nabi T, Rafiq N, Rahman MH, Rasool S, Wani NU. Comparative study of emphysematous pyelonephritis and pyelonephritis in type 2 diabetes: a single-centre experience. J Diabetes Metab Disord. 2020, 19:1273-82. 10.1007\/s40200-020-00640-y","journal-title":"J Diabetes Metab Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3339\/jkspn.2016.20.2.74","article-title":"Prognostic factors of renal scarring on follow-up DMSA scan in children with acute pyelonephritis","volume":"20","author":"Lee J","year":"2016","unstructured":"Lee J, Woo BW, Kim HS. Prognostic factors of renal scarring on follow-up DMSA scan in children with acute pyelonephritis. Child Kidney Dis. 2016, 20:74-8. 10.3339\/jkspn.2016.20.2.74","journal-title":"Child Kidney Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000884","article-title":"Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?","volume":"35","author":"Bassetti M","year":"2022","unstructured":"Bassetti M, Vena A, Labate L, Giacobbe DR. Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?. Curr Opin Infect Dis. 2022, 35:568-74. 10.1097\/QCO.0000000000000884","journal-title":"Curr Opin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321536-clinical-outcomes-of-acute-pyelonephritis-in-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T01:30:32Z","timestamp":1733016632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321536-clinical-outcomes-of-acute-pyelonephritis-in-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.74865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}